Janis M. Taube
Distinguished in Melanoma

Dr. Janis M. Taube

Dermatology | Pathology
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 

Distinguished in Melanoma
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Dr. Taube is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.

Her clinical research consists of co-authoring 198 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 54 articles and participated in 1 clinical trial in the study of Melanoma.

Residency
Johns Hopkins University School of Medicine, Pathology, 2008
Specialties
Dermatology
Pathology
Licenses
Dermatology in MD
Board Certifications
American Board Of Pathology
Fellowships
Stanford University School of Medicine, Dermatopathology, 2009
Hospital Affiliations
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

The Johns Hopkins Hospital
Baltimore, MD 21287
Call: 410-955-5000

Additional Areas of Focus

Dr. Taube has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Merkel Cell Carcinoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.
Enrollment Status: Active_not_recruiting
Publish Date: December 03, 2025
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
In Situ Vaccination With Stereotactic Body Radiation Therapy (SBRT) as a Strategy to Overcome Resistance to Immune Checkpoint Blockade: a Phase II Clinical Trial of SBRT and Anti-PD-1 Therapy With Immunologic Correlates
In Situ Vaccination With Stereotactic Body Radiation Therapy (SBRT) as a Strategy to Overcome Resistance to Immune Checkpoint Blockade: a Phase II Clinical Trial of SBRT and Anti-PD-1 Therapy With Immunologic Correlates
Enrollment Status: Withdrawn
Publish Date: April 12, 2021
Intervention Type: Radiation, Drug
Study Drug: Nivolumab Intravenous Solution [OPDIVO]
Study Phase: Phase 2
View 1 Less Clinical Trial

198 Total Publications

Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
View All 198 Publications
Similar Doctors
Elite in Melanoma
Dr. Suraj S. Venna
Dermatology
Elite in Melanoma
Dr. Suraj S. Venna
Dermatology

Inova Health Care Services

8081 Innovation Park Dr, 
Fairfax, VA 
 (45.4 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Suraj Venna is a Dermatologist in Fairfax, Virginia. Dr. Venna is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Venna is currently accepting new patients.

Sewon Kang
Distinguished in Melanoma
Dr. Sewon Kang
Dermatology
Distinguished in Melanoma
Dr. Sewon Kang
Dermatology

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Languages Spoken:
English, Korean
See accepted insurances

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Acne, Prurigo Nodularis, and Rosacea.

Jihad Alhariri
Distinguished in Melanoma
Dr. Jihad Alhariri
Dermatology
Distinguished in Melanoma
Dr. Jihad Alhariri
Dermatology

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 8, Floor 8, 
Baltimore, MD 
 (1.2 miles away)
410-955-5933
Languages Spoken:
English, Arabic, French
See accepted insurances

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

VIEW MORE MELANOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taube's expertise for a condition
ConditionClose
    • Distinguished
    • Melanoma
      Dr. Taube is
      Distinguished
      . Learn about Melanoma.
      See more Melanoma experts
    • Merkel Cell Carcinoma
      Dr. Taube is
      Distinguished
      . Learn about Merkel Cell Carcinoma.
      See more Merkel Cell Carcinoma experts
    • Advanced
    • Basal Cell Skin Cancer
      Dr. Taube is
      Advanced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Experienced
    • Epidermoid Cyst
      Dr. Taube is
      Experienced
      . Learn about Epidermoid Cyst.
      See more Epidermoid Cyst experts
    • Graft Versus Host Disease (GvHD)
      Dr. Taube is
      Experienced
      . Learn about Graft Versus Host Disease (GvHD).
      See more Graft Versus Host Disease (GvHD) experts
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Dr. Taube is
      Experienced
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
    • Histiocytosis
      Dr. Taube is
      Experienced
      . Learn about Histiocytosis.
      See more Histiocytosis experts
    • Lichen Planus
      Dr. Taube is
      Experienced
      . Learn about Lichen Planus.
      See more Lichen Planus experts
    • Lichen Sclerosus
      Dr. Taube is
      Experienced
      . Learn about Lichen Sclerosus.
      See more Lichen Sclerosus experts
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.